Acorda Therapeutics (ACOR) Q3 2023 Earnings

Nov 13Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-7.55
-4.84
-2.14
0.57

Details

Expected EPS
N/A
Actual EPS
-7.16
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Acorda Therapeutics⁩ (⁦ACOR⁩) has reported earnings of ⁦-7.16⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts